Patients Labour, the NHS, and life sciences: Partnerships and people The United Kingdom this morning woke to landslide poll results: Labour is in on just 34% of the vote following the worst Conservative defeat in the party’s history.
R&D Pharma gets ruthless as job losses mount across industry The industry is showing its teeth, as companies have started slashing positions.
Sales & Marketing Sponsored Patient-centricity and HCP engagement: 7 challenges in pharm... Healthcare professional (HCP) engagement is a term known to everyone who’s trying to win attention in the domain of pharma.
R&D Digitalising supply chains may be the zeitgeist, but let’s n... The pharmaceutical industry is on the cusp of a digital revolution.
Digital Redefining pharmaceutical case processing in the age of AI a... Pharmaceutical case processing is witnessing a 15% annual increase in adverse event reports, according to
Sales & Marketing The drug pricing discussion that won’t disappear Discussions of the pharma industry in the political sphere have lingered on pricing for a number of years.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends